Global biopharma Eli Lilly will acquire SiteOne Therapeutics, a biotech dedicated to the development of non-opioid medicines to […]
Category: News
First non-immunosuppressive dual-action therapy approved for eligible patients
Company secures regulatory approvals for commercial rollout in UK and US
The Board of the Medicines and Healthcare products Regulatory Agency (MHRA) has met in Scotland for the first […]
Strategic collaboration aims to improve early diagnosis
The drug was recently approved in the US for familial chylomicronaemia syndrome
Brekiya is now the first DHE auto-injector to be approved by the regulator
Regulator confirms safety and efficacy of new treatment option for patient
Biotech spin-off targets fibrosis, neoplasm and neovascularization
Aspire-FTD study aims to stop disease progression with one-time treatment